Posts by: Catarina Silva, MSc

Catarina Silva, MSc

With over three years of experience in the medical communications business, Catarina holds a BSc. in Biomedical Sciences and a MSc. in Neurosciences. Apart from writing, she has been involved in patient-oriented translational and clinical research.

January 27, 2020January 27, 2020

Education Strategies May Improve IBD Patients’ School Attendance, UK Study Suggests

News

Many more children and young people with inflammatory bowel disease (IBD) miss school or college classes compared with their IBD-free peers, an English study shows. The study found patients’ main ... Read more

December 11, 2019December 11, 2019

Engitix, Morphic Partner to Identify New Ways of Treating Intestinal Fibrosis in IBD Patients

News

Engitix and Morphic Therapeutic announced the start of a research partnership into extracellular matrix targets for treating inflammatory bowel disease (IBD) with intestinal fibrosis, known as fibrostenotic IBD. The extracellular matrix ... Read more

June 7, 2019June 7, 2019

Mirikizumab Reduces Disease Activity in Active Crohn’s Disease, Phase 2 Trial Shows

News

Treatment with Elli Lilly’s mirikizumab led to a significant reduction in disease activity in moderate and severe Crohn’s disease patients after 12 weeks of treatment, findings from a Phase 2 ... Read more

June 5, 2019June 5, 2019

Salix, Mitsubishi Tanabe Pharma to Develop and Commercialize MT-1303 for IBD

News

Mitsubishi Tanabe Pharma and Salix Pharmaceuticals have entered into an exclusive licensing agreement for MT-1303 (amiselimod), a therapeutic agent for autoimmune diseases including inflammatory bowel disease (IBD) and ulcerative colitis. ... Read more

May 22, 2019May 22, 2019

Helmsley Charitable Trust Grants $1.8 Million Toward Crohn’s Disease Research

News

The Leona M. and Harry B. Helmsley Charitable Trust has donated $1.8 million for the development of a gut-mimicking microdevice to help scientists better understand Crohn’s disease and develop new therapies. The technology ... Read more

October 23, 2018October 24, 2018

IBD Diagnosed in Children Can Put Them at Risk of Earlier Death, Study Finds

News

Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease, diagnosed in childhood puts these patients — particularly those with severe disease or complications like cancer — at a higher ... Read more

July 23, 2018July 23, 2018

Nextbiotix Receives €7 Million for Development of Bacteria-based IBD Therapy

News

Nextbiotix has secured €7 million ($8.2 million) in funding to develop NBX1650, the company’s lead bacterial candidate for the treatment of inflammatory bowel disease (IBD). This first round of funding ... Read more

May 9, 2018May 9, 2018

Atlantic Healthcare Completes Phase 3 Trial Enrollment for Alicaforsen as Pouchitis Treatment

News

Atlantic Healthcare has completed enrollment for a Phase 3 trial evaluating the safety and efficacy of alicaforsen in patients with pouchitis, a frequent complication after surgery to treat different forms ... Read more

April 16, 2018April 16, 2018

Doctors Should Talk About Pregnancy to Women with IBD, Study Suggests

News

Researchers recommend healthcare professionals talk to women with inflammatory bowel disease (IBD) about pregnancy early in their treatment so they can make a well-informed decision about whether to have children. ... Read more

April 2, 2018April 2, 2018

Protagonist Halts Clinical Trial of PTG-100 for UC After Analysis Finds Study Futile

News

A Phase 2b trial of PTG-100, an investigative therapy for moderate-to-severe ulcerative colitis (UC), has been discontinued after an interim analysis deemed the study futile, according to Protagonist Therapeutics. The randomized, ... Read more